Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02160860
Other study ID # HY201405-HP
Secondary ID
Status Completed
Phase N/A
First received June 4, 2014
Last updated August 14, 2016
Start date May 2014
Est. completion date June 2016

Study information

Verified date August 2016
Source Children's Hospital of Fudan University
Contact n/a
Is FDA regulated No
Health authority China: Ministry of Health
Study type Observational

Clinical Trial Summary

Epidemiology of Helicobacter Pylori Infection Among Shanghai Children.


Description:

To get an understanding of the Hp infection general situation and provide evidence for Hp control, we are planning to run a free physical examination and lab test for a group of children. We are going to proceed with Hp-IgG test, 13C urea breath test and salivary Hp urea antigen test together to screening and diagnosing it.


Recruitment information / eligibility

Status Completed
Enrollment 1997
Est. completion date June 2016
Est. primary completion date September 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 3 Years to 18 Years
Eligibility Inclusion Criteria:

- Age 3~18

- Not been Clinical diagnosis of

Exclusion Criteria:

- Had antibiotics in the past week

- Had Bismuth or PPI

Study Design

Observational Model: Ecologic or Community, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Locations

Country Name City State
China Pujiang Community Health Service Center Shanghai Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Children's Hospital of Fudan University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary HP Infection Rate Estimation for Shanghai Children Get the population of infection with HP and calculate the infection rate for the sampling group, to estimate the infection rate for whole population of Shanghai children Sampling complete before June 30, 2014. Lab test finish within 10 weeks. Report release within 3 weeks after all test finished. No
See also
  Status Clinical Trial Phase
Recruiting NCT02553083 - High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection Phase 4
Completed NCT01897909 - The Impact of Helicobacter Pylori Infection on Immune Regulation and Clinical Course in HIV Patients in Ghana
Completed NCT03367897 - Bleeding Ulcer and Erosions Study "BLUE Study"
Completed NCT01506986 - Helicobacter Eradication Aspirin Trial Phase 4
Recruiting NCT01572597 - Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy Phase 4
Recruiting NCT02164409 - Changes Associated With H. Pylori and Gastric Carcinogenesis
Completed NCT01623154 - POCone-UBiT-IR300 Pediatric Comparison Study Phase 4
Completed NCT01591486 - Helicobacter Pylori and the Long-term Risk of Peptic Ulcer Bleeding N/A
Completed NCT03124199 - Rifaximin Associated With Classic Triple Therapy for the Eradication of Helicobacter Pylori Infection Phase 3
Recruiting NCT02674802 - Reinfection After Eradication of Helicobacter Pylori Infection N/A
Completed NCT02092506 - RCT: Triple vs Sequential vs Concomitant Therapy H Pylori Phase 4
Completed NCT01902589 - Resistance of Helicobacter Pylori to Antibiotics in Children N/A